David van der Poorten

Dr. David van der Poorten is a Clinical Senior Lecturer at the University of Sydney's Westmead Clinical School, specializing in Gastroenterology and Hepatology. With over 15 years of clinical and research experience, his work bridges critical aspects of liver disease pathogenesis, microbiome interactions, and immunological responses in viral hepatitis.

• University of Sydney
• Westmead Clinical School
• Department of Gastroenterology and Hepatology

His research portfolio demonstrates deep engagement with:

• Non-Alcoholic Fatty Liver Disease (NAFLD/NASH) mechanisms and metabolic interactions
• Immunological responses in chronic hepatitis B and C
• Microbiome studies in liver disease and Parkinson's disease
• Biomarker development for hepatocellular carcinoma
• Microbial translocation and phage dynamics

Key article trends show:

• 2024 focus on colonoid models and Parkinson's microbiome interventions
• 2023 translational studies on C. difficile and regulatory frameworks
• 2022 global consensus building for MAFLD
• 2021-2020 advancements in NK cell immunology and fibrosis markers
• 2019-2018 clinical endoscopy and microbiome research
• 2017-2007 foundational work in fatty liver disease and Helicobacter pylori

Dr. van der Poorten maintains active clinical practice at Sydney's leading hospitals while participating in:

• Multi-Disciplinary Meetings
• Advanced Therapeutic Endoscopy programs
• Clinical Trials
• Fibroscan implementation